Corrective Actions Lead Beijing FDA To Lift Drug Ad Suspensions, But SFDA Uncovers More Infractions
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State Food and Drug Administration Nov. 7 issued a report summarizing illegal pharmaceutical and medical device advertisements uncovered by China's local FDAs, and announced that advertising licenses for nine drugs and seven medical devices would be suspended for one year because of incorrect or exaggerated content